News
Scientists treated a person’s type 1 diabetes with genetically modified insulin-producing cells that evaded immune system attacks. This is the first therapy for the condition that does not require imm ...
In a series of landmark studies published in the journals Nature (2010, 2014 and 2019), Nature Cell Biology (2018) and Nature Communications (2021), the laboratory has discovered that, after ...
In the new study, the researchers transplanted grafts of living human pancreatic islets (cell clusters containing beta cells) into the kidneys of diabetic and nondiabetic mice.
A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar ...
A common type of human papillomavirus (HPV) could be more dangerous than we thought. The virus, known as beta-HPV, was ...
Biomea Fusion, Inc. announced positive results from preclinical experiments showing that its investigational drug icovamenib enhances beta cell function and improves the responsiveness of human ...
15d
ZME Science on MSNA Man With Type 1 Diabetes Produces His Own Insulin After Receiving Millions of Gene Edited Pancreatic Cells
In a hospital in Sweden, surgeons made a small cut in a man’s forearm and injected millions of tiny clusters of donor cells. The 42-year-old had lived with type 1 diabetes for nearly 40 years, his ...
An ambitious project launched in 2016 has made a dent in one of biology’s greatest challenges — with more than 3,600 researchers profiling more than 100 million cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results